← Leaderboards
Erika S. Berman-Rosenzweig
Johns Hopkins University
$2,160,271
Attributed
$5,694,540
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,694,540 · 3
By mechanism
UH3$3,169,398 · 1
U01$1,572,547 · 1
UG3$952,595 · 1
Top collaborators
- Evelyn Horn5 shared
- Steven Herbert Abman4 shared
- Lewis H Romer4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Steven Herbert Abman$28,175,515
- Marshall H Montrose$9,326,939
- Dorry Segev$40,743,790
- David Alan Kass$45,555,857
- Stuart C Ray$7,743,036
Others in their field
Top investigators on “Therapeutic Intervention”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$297,163,567
- Leonard Freedman · Leidos Biomedical Research, Inc.$269,117,714
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
Research focus
Therapeutic InterventionLungSitePulmonary HypertensionFutureEvaluationHemodynamicsPerformanceClassificationBaseCdna LibraryBiological MarkersBloodBlood CirculationBioinformaticsActive MethodCessation Of LifeBiochemicalCaringCandidate Disease GeneCase SeriesCategoriesCav1 GeneBiobank
Grant awards (9)
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$652,233
UH3 · FY2025 · HL
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$1,218,226
UH3 · FY2024 · HL
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$1,298,939
UH3 · FY2023 · HL
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension$952,595
UG3 · FY2021 · HL
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$328,855
U01 · FY2018 · HL · contact PI
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$328,855
U01 · FY2017 · HL · contact PI
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$328,855
U01 · FY2016 · HL · contact PI
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$323,922
U01 · FY2015 · HL · contact PI
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$262,060
U01 · FY2014 · HL · contact PI